ArticleEnvironmental science & technology2021
Contribution of Nonaqueous-Phase Liquids to the Retention and Transport of Per and Polyfluoroalkyl Substances (PFAS) in Porous Media.
Article in Environmental science & technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Review
- Effects of anionic hydrocarbon surfactant on the transport of perfluorooctanoic acid (PFOA) in natural soils.Environmental science and pollution research international · 2022Article
- The impact of multiple-component PFAS solutions on fluid-fluid interfacial adsorption and transport of PFOS in unsaturated porous media.The Science of the total environment · 2022Article
- The influence of molecular structure on PFAS adsorption at air-water interfaces in electrolyte solutions.Chemosphere · 2021Article
- Ideal versus Nonideal Transport of PFAS in Unsaturated Porous Media.Water research · 2021Article
- Transport of PFOS in aquifer sediment: Transport behavior and a distributed-sorption model.The Science of the total environment · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Per and polyfluoroalkyl substances (PFAS) cocontamination with nonaqueous-phase organic liquids (NAPLs) has been observed or suspected at various sites, particularly at fire-training areas at which aqueous film-forming foams (AFFFs) were applied. The objectives of this study are to (1) delineate the relative significance of specific PFAS-NAPL processes on PFAS retention, including partitioning into the bulk NAPL phase and adsorption to the NAPL-water interface; (2) investigate the influence of NAPL properties, saturation, and mass-transfer constraints on PFAS retention; and (3) determine whether PFAS may impact NAPL distribution through mobilization or dissolution. Perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) are used as representative PFAS, and trichloroethene (TCE) and decane are used as representative NAPLs. NAPL-water interfacial adsorption was quantified with NAPL-water interfacial-tension measurements; partitioning into NAPL was quantified with batch experiments, and retardation factors (R) in the absence and presence of residual NAPL were determined with miscible-displacement transport experiments. R values increased in the presence of residual NAPL, with adsorption to the NAPL-water interface accounting for as much as ∼77% of retention and solid-phase adsorption also significantly contributing to retention. Additionally, this study provides the first QSPR analysis focused on NAPL-water interfacial adsorption coefficients, with results consistent with those from previous air-water studies. Lastly, this initial investigation into PFAS impacts on NAPL behavior determined that PFOS/PFOA are unlikely to enhance solubilization or mobilization of NAPL under the conditions present at many AFFF legacy sites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.